BioSpace News Archive

Sonoma Pharmaceuticals, Inc. announced that Reliefacyn® Advanced Itch-Burn-Rash-Pain Relief Hydrogel has received the National Eczema Association Seal of Acceptance™.

Humacyte, Inc. presented yesterday at MHSRS the clinical results of a year-long humanitarian program in Ukraine.

Medela, the healthcare choice for more than six million hospitals around the world*, announced today that it will introduce a new innovative sterile dressing within its negative pressure wound therapy (NPWT) portfolio in September.

Mainz Biomed N.V., a molecular genetics diagnostic company specializing in the early detection of cancer, announced the results of the first six months and second quarter ending June 30, 2023 and provided a corporate update.

Calliditas Therapeutics AB announced publication in The Lancet of the full data from the Phase 3 NefIgArd Study with Nefecon® delayed release capsules/Kinpeygo®) in adults with Primary IgA nephropathy.

Asieris Pharmaceuticals announced that the Government of Hong Kong Special Administrative Region Department of Health has approved the registration applications for the Uro-G and Uro-V disposable cystoscopic system.

Scientists at City of Hope, one of the largest cancer research and treatment organizations in the United States and a leading research center for diabetes and other life-threatening illnesses, have identified a cell metabolism process found in men with diabetes and metastatic prostate cancer that could one day lead to improved testing and treatments for Black men with these diseases.

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced its unaudited financial results for the six months ended June 30, 2023.

Myriad Genetics, Inc. , (NASDAQ: MYGN) a leader in genetic testing and precision medicine, today announced the integration of Absolute Risk Reduction (ARR) into the Prolaris ® Prostate Cancer Prognostic Test to help patients and providers make personalized treatment decisions regarding hormone therapy.

Bio-Path Holdings, Inc., today announced its financial results for the second quarter ended June 30, 2023 and provided an update on recent corporate developments.